Does the meld system provide equal access to liver transplantation for patients with different ABO blood groups?

Alexander J. C. IJtsma*, Christian S. van der Hilst, Danielle M. Nijkamp, Jan T. Bottema, Vaclav Fidler, Robert J. Porte, Maarten J. H. Slooff

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

3 Citations (Scopus)


This study investigates the relationship between blood group and waiting time until transplantation or death on the waiting list. All patients listed for liver transplantation in the Netherlands between 15 December 2006 and 31 December 2012, were included. Study variables were gender, age, year of listing, diagnosis, previous transplantations, blood group, urgency, and MELD score. Using a competing risks analysis, separate cumulative incidence curves were constructed for death on the waiting list and transplantation and used to evaluate outcomes.In 517 listings, the mean death rate per 100 patient-years was 10.4. A total of 375 (72.5% of all listings) were transplanted. Of all transplantations, 352 (93.9%) were ABO-identical and 23 (6.1%) ABO-compatible. The 5-year cumulative incidence of death was 11.2% (SE 1.4%), and of transplantation 72.5% (SE 2.0%). Patient blood group had no multivariate significant impact on the hazard of dying on the waiting list nor on transplantation. Age, MELD score, and urgency status were significantly related to the death on the waiting list and transplantation. More recent listing had higher probability of being transplanted. In the MELD era, patient blood group status does not have a significant impact on liver transplant waiting list mortality nor on waiting time for transplantation.

Original languageEnglish
Pages (from-to)883-889
Number of pages7
JournalTransplant International
Issue number8
Publication statusPublished - Aug-2016


  • donation
  • donor registries
  • liver clinical
  • outcome
  • selection criteria

Cite this